Systemic corticosteroids in treatment of chronic rhinosinusitis—A systematic review

Thank References

• Ho J, Li W, Grayson JW, et al. Systemic medication requirement in post-surgical patients with eosinophilic chronic rhinosinusitis. Rhinology. 2021;59(1):59–18. doi: 10.4193/Rhin20.073
   PubMed Web of Science ®Google Scholar
• Giordano J, Darras J, Chevalier D, et al. Preoperative corticosteroid treatment and nasal polyposis. Ann Otolaryngol Chir Cervicofac. 2009;126(3):120–124. doi: 10.1016/j.aorl.2009.03.005
   PubMedGoogle Scholar
• Fokkens WJ, Lund VJ, Hopkins C, et al. Executive summary of EPOS 2020 including integrated care pathways. Rhinology. 2020;58(2):82–111. doi: 10.4193/Rhin20.601
   PubMedGoogle Scholar
• Hellings PW, Klimek L, Cingi C, et al. Non-allergic rhinitis: position paper of the european academy of allergy and clinical immunology. Allergy. 2017;72(11):1657–1665. doi: 10.1111/all.13200
   PubMed Web of Science ®Google Scholar
• Hellings PW, Scadding G, Bachert C, et al. EUFOREA treatment algorithm for allergic rhinitis. Rhinology. 2020;58(6):618–622. doi: 10.4193/Rhin20.376
   PubMed Web of Science ®Google Scholar
• Parente L. Deflazacort: therapeutic index, relative potency and equivalent doses versus other corticosteroids. BMC Pharmacol Toxicol. 2017;18(1):1. doi: 10.1186/s40360-016-0111-8
   PubMedGoogle Scholar
• Kirtsreesakul V, Wongsritrang K, Ruttanaphol S. Clinical efficacy of a short course of systemic steroids in nasal polyposis. Rhinology. 2011;49(5):525–532. doi: 10.4193/Rhino11.140
   PubMed Web of Science ®Google Scholar
• ClinCals. (2015, October 24). Corticosteroid Conversion Calculator. Retrieved from ClinCals: https://clincalc.com/corticosteroids/
   Google Scholar
• Price DB, Trudo F, Voorham J, et al. Adverse outcomes from initiation of systemic corticosteroids for asthma: long-term observational study. J Asthma Allergy. 2018;11:193–204. doi: 10.2147/JAA.S176026
   PubMed Web of Science ®Google Scholar
• Warrington TP, Bostwick JM. Psychiatric adverse effects of corticosteroids. Mayo Clin Proc. 2006;81(10):1361–1367. doi: 10.4065/81.10.1361
   PubMed Web of Science ®Google Scholar
• Goodwin JE, Geller DS. Glucocorticoid-induced hypertension. Pediatr Nephrol. 2012;27(7):1059–1066. doi: 10.1007/s00467-011-1928-4
   PubMed Web of Science ®Google Scholar
• Hirsch IB, Paauw DS. Diabetes management in special situations. Endocrinol Metab Clin North Am. 1997;26(3):631–645. doi: 10.1016/S0889-8529(05)70271-1
   PubMed Web of Science ®Google Scholar
• Segal BH, Sneller MC. Infectious complications of immunosuppressive therapy in patients with rheumatic diseases. Rheum Dis Clin North Am. 1997;23(2):219–237. doi: 10.1016/S0889-857X(05)70327-6
   PubMed Web of Science ®Google Scholar
• Da Silva JA, Jacobs JW, Kirwan JR, et al. Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data. Ann Rheum Dis. 2006;65(3):285–293. doi: 10.1136/ard.2005.038638
   PubMed Web of Science ®Google Scholar
• Ameratunga R. Gluteal subcutaneous atrophy after depot steroid injection for allergic rhinitis. World Allergy Organ J. 2012;5(11):168–169. doi: 10.1097/WOX.0b013e3182758d80
   PubMedGoogle Scholar
• Stanbury RM, Graham EM. Systemic corticosteroid therapy–side effects and their management. Br J Ophthalmol. 1998;82(6):704–708. doi: 10.1136/bjo.82.6.704
   PubMed Web of Science ®Google Scholar
• Keenan GF. Management of complications of glucocorticoid therapy. Clin Chest Med. 1997;18(3):507–520. doi: 10.1016/S0272-5231(05)70398-1
   PubMed Web of Science ®Google Scholar
• Bonfils P, Halimi P, Malinvaud D. Adrenal suppression and osteoporosis after treatment of nasal polyposis. Acta Otolaryngol. 2006;126(11):1195–1200. doi: 10.1080/00016480600672667
   PubMed Web of Science ®Google Scholar
• Fardet L, Kassar A, Cabane J, et al. Corticosteroid-induced adverse events in adults: frequency, screening and prevention. Drug Saf. 2007;30(10):861–881. doi: 10.2165/00002018-200730100-00005
   PubMed Web of Science ®Google Scholar
• Buchman AL. Side effects of corticosteroid therapy. J Clin Gastroenterol. 2001;33(4):289–294. doi: 10.1097/00004836-200110000-00006
   PubMed Web of Science ®Google Scholar
• Aasbjerg K, Torp-Pedersen C, Backer V. Specific immunotherapy can greatly reduce the need for systemic steroids in allergic rhinitis. Allergy. 2012;67(11):1423–1429. doi: 10.1111/all.12023
   PubMed Web of Science ®Google Scholar
• Jankowski R, Bodino C. Olfaction in patients with nasal polyposis: effects of systemic steroids and radical ethmoidectomy with middle turbinate resection (nasalization). Rhinology. 2003;41(4):220–230.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLOS Med. 2009;6(7):e1000097. doi: 10.1371/journal.pmed.1000097
   PubMed Web of Science ®Google Scholar
• Page MJ, Moher D, Bossuyt PM, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;372:n160. doi: 10.1136/bmj.n160
   PubMed Web of Science ®Google Scholar
• Akiyama K, Makihara S, Uraguchi K, et al. Impact of preoperative systemic corticosteroids on the histology and diagnosis of eosinophilic chronic rhinosinusitis. Int Arch Allergy Immunol. 2019;179(2):81–88. doi: 10.1159/000496437
   PubMed Web of Science ®Google Scholar
• Rives P, Espitalier F, Michel G, et al. Prospective evaluation of oral corticosteroid as a predictor of postoperative olfactory recovery after functional endoscopic surgery for nasal polyposis. Eur Arch Otorhinolaryngol. 2019;276(12):3359–3366. doi: 10.1007/s00405-019-05537-y
   PubMed Web of Science ®Google Scholar
• Shen KH, Wang YH, Hsu TW, et al. Differential effects of postoperative oral corticosteroid on eosinophilic vs. non-eosinophilic CRSwNP subtypes. Am J Otolaryngol. 2019;40(1):22–29. doi: 10.1016/j.amjoto.2018.09.005
   PubMed Web of Science ®Google Scholar
• Ecevit MC, Erdag TK, Dogan E, et al. Effect of steroids for nasal polyposis surgery: A placebo-controlled, randomized, double-blind study. Laryngoscope. 2015;125(9):2041–2045. doi: 10.1002/lary.25352
   PubMed Web of Science ®Google Scholar
• Wright ED, Agrawal S. Impact of perioperative systemic steroids on surgical outcomes in patients with chronic rhinosinusitis with polyposis: evaluation with the novel Perioperative Sinus Endoscopy (POSE) scoring system. Laryngoscope. 2007;117(11 Pt 2 Suppl 115):1–28. doi: 10.1097/MLG.0b013e31814842f8
   PubMed Web of Science ®Google Scholar
• Chang MT, Noel J, Ayoub NF, et al. Oral corticosteroids following endoscopic sinus surgery for chronic rhinosinusitis without nasal polyposis: a randomized clinical trial. JAMA Otolaryngology–Head & Neck Surg. 2021;147(5):434–441. doi: 10.1001/jamaoto.2021.0011
   PubMed Web of Science ®Google Scholar
• Arancibia C, Langdon C, Mullol J, et al. Lack of additive benefit of oral steroids on short-term postoperative outcomes in nasal polyposis. Laryngoscope. 2020;130(12):2742–2747. doi: 10.1002/lary.28347
   PubMed Web of Science ®Google Scholar
• Workman AD, Miyake MM, Nocera AL, et al. Unexpected effects of systemic steroids on the CRSwNP proteome: is protein upregulation more important than inhibition? Int Forum Allergy Rhinol. 2020;10(3):334–342. doi: 10.1002/alr.22497
   PubMed Web of Science ®Google Scholar
• Watanabe S, Pinto JM, Bashir ME, et al. Effect of prednisone on nasal symptoms and peripheral blood T-cell function in chronic rhinosinusitis. Int Forum Allergy Rhinol. 2014;4(8):609–616. doi: 10.1002/alr.21336
   PubMed Web of Science ®Google Scholar
• Karaki M, Akiyama K, Mori N. Efficacy of intranasal steroid spray (mometasone furoate) on treatment of patients with seasonal allergic rhinitis: comparison with oral corticosteroids. Auris Nasus Larynx. 2013;40(3):277–281. doi: 10.1016/j.anl.2012.09.004
   PubMed Web of Science ®Google Scholar
• Ekinci A. The effects of systemic steroid therapy on macrophage migration inhibitory factor concentrations in patients with nasal polyps. J Laryngol Otol. 2018;132(10):891–895. doi: 10.1017/S0022215118001652
   PubMed Web of Science ®Google Scholar
• Grammer LC. Doxycycline or oral corticosteroids for nasal polyps. J Allergy Clin Immunol Pract. 2013;1(5):541–542. doi: 10.1016/j.jaip.2013.04.010
   PubMed Web of Science ®Google Scholar
• De Silva AP, Schembri MA, Sarah AH, et al. Short-term Oral Steroids Significantly Improves Chronic Rhinosinusitis without Nasal Polyps. Laryngoscope. 2021;131(10):E2618–e26. doi: 10.1002/lary.29495
   PubMed Web of Science ®Google Scholar
• Yigit O, Acioğlu E, Gelişgen R, et al. The effect of corticosteroid on metalloproteinase levels of nasal polyposis. Laryngoscope. 2011;121(3):667–673. doi: 10.1002/lary.21462
   PubMed Web of Science ®Google Scholar
• Vaidyanathan S, Williamson P, Anderson K, et al. Effect of systemic steroids on humming nasal nitric oxide in chronic rhinosinusitis with nasal polyposis. Ann Allergy Asthma Immunol. 2010;105(6):412–417. doi: 10.1016/j.anai.2010.08.017
   PubMed Web of Science ®Google Scholar
• Won TB, Jang E, Min SK, et al. Treatment outcomes and predictors for systemic steroids in nasal polyposis. Acta Otolaryngol. 2012;132 Suppl 1:S82–7. doi: 10.3109/00016489.2012.659753
   PubMed Web of Science ®Google Scholar
• Yazici D, Ü T, Uğuz A. The effect of corticosteroid therapy on cyclooxygenase 2, vascular endothelial growth factor, and inducible nitric oxide synthase expression levels in nasal polyposis. Eur Arch Otorhinolaryngol. 2014;271(6):1541–1547. doi: 10.1007/s00405-013-2718-3
   PubMed Web of Science ®Google Scholar
• Goektas O, Lau L, Olze H. Treatment of chronic rhinosinusitis with pressure-pulsed corticosteroid inhalation. Indian J Otolaryngol Head Neck Surg. 2013;65(Suppl 2):402–405. doi: 10.1007/s12070-013-0625-y
   PubMedGoogle Scholar
• Lennard CM, Mann EA, Sun LL, et al. Interleukin-1 beta, interleukin-5, interleukin-6, interleukin-8, and tumor necrosis factor-alpha in chronic sinusitis: response to systemic corticosteroids. Am J Rhinol. 2000;14(6):367–373. doi: 10.2500/105065800779954329
   PubMedGoogle Scholar
• Bolger WE, Joshi AS, Spear S, et al. Gene expression analysis in sinonasal polyposis before and after oral corticosteroids: a preliminary investigation. Otolaryngol Head Neck Surg. 2007;137(1):27–33. doi: 10.1016/j.otohns.2007.01.023
   PubMed Web of Science ®Google Scholar
• Tuncer U, Soylu L, Aydogan B, et al. The effectiveness of steroid treatment in nasal polyposis. Auris Nasus Larynx. 2003;30(3):263–268. doi: 10.1016/S0385-8146(03)00051-8
   PubMed Web of Science ®Google Scholar
• Hissaria P, Smith W, Wormald PJ, et al. Short course of systemic corticosteroids in sinonasal polyposis: a double-blind, randomized, placebo-controlled trial with evaluation of outcome measures. J Allergy Clin Immunol. 2006;118(1):128–133. doi: 10.1016/j.jaci.2006.03.012
   PubMed Web of Science ®Google Scholar
• Berkiten G, Salturk Z, Topaloğlu İ. Efficacy of systemic steroid treatment in sinonasal polyposis. J Craniofac Surg. 2013;24(3):e305–8. doi: 10.1097/SCS.0b013e31828f261f
   PubMed Web of Science ®Google Scholar
• Woodworth BA, Joseph K, Kaplan AP, et al. Alterations in eotaxin, monocyte chemoattractant protein-4, interleukin-5, and interleukin-13 after systemic steroid treatment for nasal polyps. Otolaryngol Head Neck Surg. 2004;131(5):585–589. doi: 10.1016/j.otohns.2004.05.028
   PubMed Web of Science ®Google Scholar
• Schriever VA, Merkonidis C, Gupta N, et al. Treatment of smell loss with systemic methylprednisolone. Rhinology. 2012;50(3):284–289. doi: 10.4193/Rhino.11.207
   PubMed Web of Science ®Google Scholar
• Benítez P, Alobid I, de Haro J, et al. A short course of oral prednisone followed by intranasal budesonide is an effective treatment of severe nasal polyps. Laryngoscope. 2006;116(5):770–775. doi: 10.1097/01.mlg.0000205218.37514.0f
   PubMed Web of Science ®Google Scholar
• Fernandes AM, Babeto E, Rahal P, et al. Expression of genes that encode the annexin-1 and galectin-1 proteins in nasal polyposis and their modulation by glucocorticoid. Braz J Otorhinolaryngol. 2010;76(2):213–218. doi: 10.1590/S1808-86942010000200011
   PubMed Web of Science ®Google Scholar
• Jankowski R, Bodino C. Evolution of symptoms associated to nasal polyposis following oral steroid treatment and nasalization of the ethmoid–radical ethmoidectomy is functional surgery for NPS. Rhinology. 2003;41(4):211–219.
   PubMed Web of Science ®Google Scholar
• Laursen LC, Faurschou P, Pals H, et al. Intramuscular betamethasone dipropionate vs. oral prednisolone in hay fever patients. Allergy. 1987;42(3):168–172. doi: 10.1111/j.1398-9995.1987.tb02194.x
   PubMed Web of Science ®Google Scholar
• Gelardi M, Barbara F, Covelli I, et al. Long-Term Therapy with Corticosteroids in Nasal Polyposis: A Bone Metabolism Assessment. Indian J Otolaryngol Head Neck Surg. 2019;71(Suppl 3):2050–2056. doi: 10.1007/s12070-018-1466-5
   PubMedGoogle Scholar
• Sahlstrand-Johnson P, Holmström M, Ehnhage A. Does the oral steroid treatment of patients with nasal polyposis cause osteopenia or osteoporosis? Clinical Otolaryngology: Official Journal Of ENT-UK; Official Journal Of Netherlands Society For Oto-Rhino-Laryngology & Cervico-Facial Surgery. 2019;44(6):1011–1016. doi: 10.1111/coa.13431
   PubMed Web of Science ®Google Scholar
• Hansel K, Marietti R, Bianchi L, et al. Cross-reactions to systemic corticosteroids in patients contact sensitized to budesonide. Contact Dermatitis. 2020;83(4):321–324. doi: 10.1111/cod.13597
   PubMed Web of Science ®Google Scholar
• Rajasekaran K, Seth R, Abelson A, et al. Prevalence of metabolic bone disease among chronic rhinosinusitis patients treated with oral glucocorticoids. Am J Rhinol Allergy. 2010;24(3):215–219. doi: 10.2500/ajra.2010.24.3445
   PubMed Web of Science ®Google Scholar
• Walford HH, Lund SJ, Baum RE, et al. Increased ILC2s in the eosinophilic nasal polyp endotype are associated with corticosteroid responsiveness. Clin Immunol. 2014;155(1):126–135. doi: 10.1016/j.clim.2014.09.007
   PubMed Web of Science ®Google Scholar
• Wen W, Liu W, Zhang L, et al. Increased neutrophilia in nasal polyps reduces the response to oral corticosteroid therapy. J Allergy Clin Immunol. 2012;129(6):1522–8.e5. doi: 10.1016/j.jaci.2012.01.079
   PubMed Web of Science ®Google Scholar
• Lu H, Lin XS, Yao DM, et al. Increased serum amyloid a in nasal polyps is associated with systemic corticosteroid insensitivity in patients with chronic rhinosinusitis with nasal polyps: a pilot study. Eur Arch Otorhinolaryngol. 2018;275(2):401–408. doi: 10.1007/s00405-017-4809-z
   PubMed Web of Science ®Google Scholar
• Hong H, Chen F, Sun Y, et al. Nasal IL-25 predicts the response to oral corticosteroids in chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. 2018;141(5):1890–1892. doi: 10.1016/j.jaci.2017.10.050
   PubMed Web of Science ®Google Scholar
• Milara J, Peiró T, Armengot M, et al. Mucin 1 downregulation associates with corticosteroid resistance in chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. 2015;135(2):470–476. doi: 10.1016/j.jaci.2014.07.011
   PubMed Web of Science ®Google Scholar
• Milara J, Morell A, Ballester B, et al. MUC4 impairs the anti-inflammatory effects of corticosteroids in patients with chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. 2017;139(3):855–62.e13. doi: 10.1016/j.jaci.2016.06.064
   PubMed Web of Science ®Google Scholar
• Radajewski K, Kalińczak-Górna P, Zdrenka M, et al. Short Term Pre-Operative Oral Corticosteroids—Tissue Remodeling in Chronic Rhinosinusitis with Nasal Polyps. J Clin Med. 2021;10(15):3346. doi: 10.3390/jcm10153346
   PubMed Web of Science ®Google Scholar
• Edward JA, Sanyal M, Ramakrishnan VR, et al. Systemic prednisone administration selectively alters granulocyte subsets in nasal polyps from aspirin-exacerbated respiratory disease and chronic rhinosinusitis patients. Int Forum Allergy Rhinol. 2013;3(11):866–876. doi: 10.1002/alr.21221
   PubMed Web of Science ®Google Scholar
• Salman S, Akpinar ME, Yigit O, et al. Surfactant protein a and D in chronic rhinosinusitis with nasal polyposis and corticosteroid response. Am J Rhinol Allergy. 2012;26(2):e76–80. doi: 10.2500/ajra.2012.26.3739
   PubMed Web of Science ®Google Scholar
• Kapucu B, Cekin E, Erkul BE, et al. The effects of systemic, topical, and intralesional steroid treatments on apoptosis level of nasal polyps. Otolaryngol Head Neck Surg. 2012;147(3):563–567. doi: 10.1177/0194599812446678
   PubMed Web of Science ®Google Scholar
• Acıoğlu E, Yigit O, Alkan Z, et al. The effects of corticosteroid on tissue lactoferrin in patients with nasal polyposis. Am J Rhinol Allergy. 2012;26(1):e28–31. doi: 10.2500/ajra.2012.26.3735
   PubMed Web of Science ®Google Scholar
• Legemiddelverk S (18 Oct 2022). Nye Metoder. Retrieved from nyemetoder.no: https://nyemetoder.no/metoder/dupilumab-dupixent-indikasjon-iv
   Google Scholar
• Medicinrådet. (26 Oct 2022). Medicinrådet. Retrieved from medicinraadet.dk: https://medicinraadet.dk/media/tx2aecsh/medicinrådets-samling-af-vurderinger-vedr-svær-crswnp-vers-1-1.pdf
   Google Scholar
• Waljee AK, Rogers MA, Lin P, et al. Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study. BMJ. 2017;357:j1415.
   PubMed Web of Science ®Google Scholar
• Salari N, Ghasemi H, Mohammadi L, et al. The global prevalence of osteoporosis in the world: a comprehensive systematic review and meta-analysis. J Orthop Surg Res. 2021;16(1):609. doi: 10.1186/s13018-021-02772-0
   PubMed Web of Science ®Google Scholar
• Walsh LJ, Lewis SA, Wong CA, et al. The impact of oral corticosteroid use on bone mineral density and vertebral fracture. Am J Respir Crit Care Med. 2002;166(5):691–695. doi: 10.1164/rccm.2110047
   PubMed Web of Science ®Google Scholar
• Selskab DE (10 2020). Glukokortikoid-Induceret Osteoporose. Retrieved from Dansk Endokrinologisk Selskab: https://endocrinology.dk/nbv/calcium-og-knoglemetabolisme/4-glukokortikoid-induceret-osteoporose/
   Google Scholar
• Buckley L, Guyatt G, Fink HA, et al. 2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis. Arthritis & Rheumat. 2017;69(8):1521–1537. doi: 10.1002/art.40137
   PubMed Web of Science ®Google Scholar
• Nasser SM, Ewan PW. Lesson of the week: Depot corticosteroid treatment for hay fever causing avascular necrosis of both hips. BMJ. 2001;322(7302):1589–1591. doi: 10.1136/bmj.322.7302.1589
   PubMedGoogle Scholar
• Østergaard MS, Østrem A, Söderström M. Hay fever and a single intramuscular injection of corticosteroid: a systematic review. Prim Care Respir J. 2005;14(3):124–130. doi: 10.1016/j.pcrj.2004.08.001
   PubMedGoogle Scholar